Potential of spice-derived phytochemicals for cancer prevention

Planta Medica

Volumn 74, Issue 13, 2008, Pages 1560-1569

  Aggarwal, Bharat B ^a   Kunnumakkara, Ajaikumar B ^a   Harlkumar, Kuzhuvelil B ^a   Tharakan, Sheeja T ^a   Sung, Bokyung ^a   Anand, Preetha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Chemoprevention; Molecular targets; Phytochemicals; Spice

Indexed keywords

ANETHOLE; CAPSAICIN; CISPLATIN; CURCUMIN; DIOSGENIN; EUGENOL; GAMBOGIC ACID; GINGER EXTRACT; GINGEROL; IFOSFAMIDE; PLANT MEDICINAL PRODUCT; RESINIFERATOXIN; ROSMARINUS OFFICINALIS EXTRACT; TERPENOID; THALIDOMIDE; THYMOQUINONE; TURMERIC; UNCLASSIFIED DRUG; URSOLIC ACID; ZERUMBONE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLACK CUMIN; CANCER INHIBITION; CANCER PREVENTION; CLOVE; COLITIS; DIABETES MELLITUS; DRUG INHIBITION; DRUG POTENTIATION; FENNEL; FENUGREEK; FLAVOR; GINGER; HUMAN; NEPHROTOXICITY; NONHUMAN; PEPPER; PERITONITIS; PROSTATE CANCER; REVIEW; ROSEMARY; SPICE; STOMACH CARCINOMA;

ANTICARCINOGENIC AGENTS; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANTS; SPICES;

CURCUMA LONGA; FOENICULUM VULGARE; NIGELLA SATIVA; TRIGONELLA FOENUM-GRAECUM; ZINGIBER OFFICINALE;

EID: 56249132710     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1074578     Document Type: Review

References (138)

1. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi C. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006; 72: 1605-21
2. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6: 203-8
3. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann NY Acad Sci 2006; 1091: 151-69
4. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71: 1397-421
5. Morre DJ, Chueh PJ, Morre DM. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U S A 1995; 92: 1831-5
6. Morre DJ, Sun E, Geilen C, Wu LY, de Cabo R, Krasagakis K et al. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer 1996; 32A: 1995-2003
7. Kang SN, Chung SW, Kim TS. Capsaicin potentiates 1,25-dihydoxyvitamin D3- and all-trans-retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Eur J Pharmacol 2001; 420: 83-90
8. Zhang J, Nagasaki M, Tanaka Y, Morikawa S. Capsaicin inhibits growth of adult T-cell leukemia cells. Leuk Res 2003; 27: 275-83
9. Zhang HZ, Kasibhatla S, Wang Y, Herich J, Guastella J, Tseng B et al. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem 2004; 12: 309-17
10. Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, Yu R et al. Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett 1997; 120: 235-41
11. Jung MY, Kang HJ, Moon A. Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett 2001; 165: 139-45
12. Qiao S, Li W, Tsubouchi R, Haneda M, Murakami K, Yoshino M. Involvement of peroxynitrite in capsaicin-induced apoptosis of C6 glioma cells. Neurosci Res 2005; 51: 175-83
13. Mon A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M et al. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 2006; 66: 3222-9
14. Singh S, Natarajan K, Aggarwal BB. Capsaicin (8-methyl-N-vanillyl- 6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol 1996; 157: 4412-20
15. Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G et al. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res 2007; 13: 3024-32
16. Skrzypczak-Jankun E, Zhou K, McCabe NP, Selman SHm, Jankun J. Structure of curcumin in complex with lipoxygenase and its significance in cancer, Int J Mol Med 2003; 12: 17-24
17. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23: 363-98
18. Gael A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809
19. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995; 270: 24995-5000
20. Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STATS phosphorylation in human multiple myeloma cells. J Immunol 2003; 171: 3863-71
21. Drukarch B, Schepens E, Stoof JC, Langeveld CH. Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes. Eur J Pharmacol 1997; 329: 259-62
22. Rompelberg CJ, Vertragen H, van Bladeren PJ. Effects of the naturally occurring alkenylbenzenes eugenol and trans-anethole on drug-metabolizing enzymes in the rat liver. Food Chem Toxicol 1993; 31: 637-45
23. Bouthillier L, Charbonneau M, Brodeur J. Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity. Toxicol Appl Pharmacol 1996; 139: 177-85
24. Stohs SJ, Lawson TA, Anderson L, Bueding E. Effects of oltipraz, BHA, ADT and cabbage on glutathione metabolism, DNA damage and lipid peroxidation in old mice. Mech Ageing Dev 1986; 37: 137-45
25. Rajakumar DV, Rao MN. Dehydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers. Biochem Pharmacol 1993; 46: 2067-72
26. Ko FN, Liao CH, Kuo YN, Lin YL. Antioxidant properties of demethyldiisoeugenol. Biochim Biophys Acta 1995; 1258: 145-52
27. Nagababu E, Lakshmaiah N. Inhibition of microsomal lipid peroxidation and monooxygenase activities by eugenol. Free Radic Res 1994; 20: 253-66
28. Mansuy D, Sassi A, Dansette PM, Plat M. A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiolthione. Biochem Biophys Res Commun 1986; 135: 1015-21
29. Taira J, Ikemoto T, Yoneya T, Hagi A, Murakami A, Makino K. Essential oil phenyl propanoids. Useful as OH scavengers? Free Radic Res Commun 1992; 16: 197-204
30. Naidu KA. Eugenol - an inhibitor of lipoxygenase-dependent lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 1995; 53: 381-3
31. Sharma JN, Srivastava KC, Gan EK. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 1994; 49: 314-8
32. Ready BS, Rao CV, Rivenson A, Kelloff G. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res 1993; 53: 3493-8
33. Ready BS. Chemoprevention of colon cancer by minor dietary constituents and their synthetic analogues. Prev Med 1996; 25: 48-50
34. Ready BS. Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents. Adv Exp Med Biol 1997; 400B: 931-6
35. Lubet RA, Steele VE, Eto I, Juliana MM, Kelloff GJ, Grubbs CJ. Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, micona-zole and phenethyl isothiocyanate in the DMBA-induced rat mammary cancer model. Int J Cancer 1997; 72: 95-101
36. al-Harbi MM, Qureshi S, Raza M, Ahmed MM, Giangreco AB, Shah AH. Influence of anethole treatment on the tumour induced by Ehrlich ascites carcinoma cells in paw of Swiss albino mice. Eur J Cancer Prev 1995; 4: 307-18
37. Chainy GB, Manna SK, Chaturvedi MM, Aggarwal BB. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000; 19: 2943-50
38. Kitayama T, Okamoto T, Hill RK, Kawai Y, Takahashi S, Yonemori S et al. Chemistry of zerumbone. 1. Simplified isolation, conjugate addition reactions, and a unique ring contracting transannular reaction of its dibromide. J Org Chem 1999; 64: 2667-72
39. Ozaki Y, Kawahara N, Harada M. Anti-inflammatory effect of Zingiber cassumunar Roxb. and its active principles. Chem Pharm Bull (Tokyo) 1991; 39: 2353-6
40. Murakami A, Takahashi M, Jiwajinda S, Koshimizu K, Ohigashi H. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-0-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus activation. Biosci Biotechnol Biochem 1999; 63: 1811-2
41. Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, Yoshihiro A et al. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha,beta-unsaturated carbonyl group is a prerequisite. Carcinogenesis 2002; 23: 795-802
42. Murakami A, Hayashi R, Tanaka T, Kwon KH, Ohigashi H, Safitri R. Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination. Biochem Pharmacol 2003; 66: 1253-61
43. Murakami A, Tanaka T, Lee JY, Surh YJ, Kim HW, Kawabata K et al. Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int J Cancer 2004; 110: 481-90
44. Tanaka T, Shimizu M, Kohno H, Yoshitani S, Tsukio Y, Murakami A et al. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci 2001; 69: 1935-45
45. Kirana C, McIntosh GH, Record IR, Jones GP. Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer 2003; 45: 218-25
46. Murakami A, Takahashi D, Koshimizu K, Ohigashi H. Synergistic suppression of Superoxide and nitric oxide generation from inflammatory cells by combined food factors. Mutat Res 2003; 523-524: 151-61
47. Murakami A, Matsumoto K, Koshimizu K, Ohigashi H. Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages. Cancer Lett 2003; 195: 17-25
48. Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 2005; 24: 6957-69
49. Puri HS, Jefferies TM, Hardman R. Diosgenin and yamogenin levels in some Indian plant samples. Planta Med 1976; 30: 118-21
50. Djerassi C. Drugs from Third World plants: the future. Science 1992; 258: 203-4
51. Segal R, Milo-Goldzweig I, Zaitschek DV. Diosgenin and yomogenin from Solanum incanum. Lloydia 1977; 40: 604
52. Dasgupta B, Pandey VB. A new Indian source of diosgenin (Costus speciosus). Experientia 1970; 26: 475-6
53. Heble MR, Narayanaswami S, Chadha MS. Diosgenin and beta-sitosterol: isolation from solanum xanthocarpum tissue cultures. Science 1967; 161: 1145
54. Madar Z, Abel R, Samish S, Arad J. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur J Clin Nutr 1988; 42: 51-4
55. Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Eur J Clin Nutr 1990; 44: 301-6
56. Gupta A, Gupta R, Lal B. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India 2001; 49: 1057-61
57. Valette G, Sauvaire Y, Baccou JC, Ribes G. Hypocholesterolaemic effect of fenugreek seeds in dogs. Atherosclerosis 1984; 50: 105-11
58. Sauvaire Y, Ribes G, Baccou JC, Loubatieeres-Mariani MM. Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek. Lipids 1991; 26: 191-7
59. Pandian RS, Anuradha CV, Viswanothan P. Gastroprotective effect of fenugreek seeds (Trigonella foenum-graecum) on experimental gastric ulcer in rats. J Ethnopharmacol 2002; 81: 393-7
60. Raju J, Patlolla JM, Swamy MV, Rao CV. Diosgenin, a steroid saponin of Trigonella foenum-graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 2004; 13: 1392-8
61. Wang SL, Cai B, Cui CB, Liu HW, Wu CF, Yao XS. Diosgenin-3-O-alpha-L-rhamnopyranosyl-(1→4)-beta-D-glucopyranoside obtained as a new anticancer agent from Dioscorea futschauensis induces apoptosis on human colon carcinoma HCT-15 cells via mitochondria-controlled apoptotic pathway.J Asian Nat Prod Res 2004; 6: 115-25
62. Moalic S, Liagre B, Corbiere C, Bianchi A, Dauca M, Bordji K et al. A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett 2001; 506: 225-30
63. Corbiere C, Liagre B, Bianchi A, Bordji K, Dauca M, Netter P et al. Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol 2003; 22: 899-905
64. Hibasami H, Moteki H, Ishikawa K, Katsuzaki H, Imai K, Yoshioka K et al. Protodioscin isolated from fenugreek (Trigonella foenum-graecum L.) induces cell death and morphological change indicative of apoptosis in leukemic cell line H-60, but not in gastric cancer cell line KATO III. Int J Mol Med 2003; 11: 23-6
65. Liu MJ, Wang Z, Ju Y, Wang RN, Wu QY. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. Cancer Chemother Pharmacol 2005; 55: 79-90
66. Leger DY, Liagre B, Corbiere C, Cook-Moreau J, Beneytout JL Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression. Int J Oncol 2004; 25: 555-62
67. Liagre B, Vergne-Salle P, Corbiere C, Charissoux JL, Beneytout JL. Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res Ther 2004; 6: R373-83
68. Corbiere C, Liagre B, Terro F, Beneytout JL. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res 2004; 14: 188-96
69. Yamada T, Hoshino M, Hayakawa T, Ohhara H, Yamada H, Nakazawa T et al. Dietary diosgenin attenuates subacute intestinal inflammation associated with indomethacin in rats. Am J Physiol 1997; 273: 355-64
70. Nappez C, Liagre B, Beneytout JL. Changes in lipoxygenase activities in human erythroleukemia (HEL) cells during diosgenin-induced differentiation. Cancer Lett 1995; 96: 133-40
71. Ondeykal JG, Herath KB, Jayasuriya H, Polishook JD, Bills CF, Dombrowski AW et al. Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3. Mol Divers 2005; 9: 123-9
72. Shishodia S, Aggarwal BB. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene 2006;25: 1463-73
73. Guo QL, Lin SS, You QD, Gu HY, Yu J, Zhao L et al. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci 2006; 78: 1238-45
74. Zhao L, Cuo QL, You QD, Wu ZQ, Gu HV. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull 2004; 27: 998-1003
75. Guo QL, You QD, Zhao L, Gu HY, Yuan ST. Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J Gastroenterol 2005; 11: 3655-9
76. Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY et al. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother Pharmacol 2006; 58: 434-43
77. Yu J, Guo QL, You QD, Zhao L, Gu HY, Yang Y et al. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis 2007; 28: 632-8
78. Wu ZQ, Guo QL, You Q, Zhao L, Cu HY. Gambogic acid inhibits proliferation of human lung carcinoma SPC-Al cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull 2004; 27: 1769-174
79. Kasibhatla S, Essen KA, Maliartchouk S, JWang JY, English NM, Drewe J et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci U S A 2005; 102: 12095-100
80. Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood 2007; 110: 3517-25
81. Yi T, Yi Z, Cho SC, Luo J, Pandey MK, Aggarwal BB et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 2008; 68: 1843-50
82. Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH. Thymoquinone is a potent Superoxide anion scavenger. Drug Chem Toxicol 2003; 26: 87-98
83. Badary OA, Abd-Ellah MF, El-Mahdy MA, Salama SA, Hamada FM. Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice. Food Chem Toxicol 2007; 45: 88-92
84. Mansour MA, Nagi MN, El-Khatib AS, Al-Bekairi AM. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell Biochem Funct 2002; 20: 143-51
85. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A et al. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol 2004; 25: 857-66
86. Badary OA. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethno-pharmacol 1999; 67: 135-42
87. Badary OA, Gamal El-Din AM. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev 2001; 25: 362-8
88. Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: a promising anti-cancer drug from natural sources, Int J Biochem Cell Biol 2006; 38: 1249-53
89. Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, Roessner A et al. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther 2007; 6: 160-9
90. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 2003; 22: 107-13
91. El-Mahdy MA, Zhu Q, Wang QE, Wani C, Warn AA. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer 2005; 117:409-17
92. Tan M, Norwood A, May M, Tucci M, Benghuzzi H. Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture. Biomed Sci Instrum 2006; 42: 363-71
93. Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella saliva L. Anticancer Res 1998; 18: 1527-32
94. Mahgoub AA. Thymoquinone protects against experimental colitis in rats.Toxicol Lett 2003; 143: 133-43
95. Haq A, Lobo PI, Al-Tufail M, Rama NR, Al-Sedairy ST. Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int J Immunopharmacol 1999; 21: 283-95
96. Hajhashemi V, Ghannadi A, Jafarabadi H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res 2004; 18: 195-9
97. Badary OA, Nagi MN, al-Shabanah OA, al-Sawaf HA, al-Sohaibani MO, al-Bekairi AM. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 1997; 75: 1356-61
98. Badary OA, Al-Shabanah OA, Nagi MN, Al-Rikabi AC, Elmazar MM. Inhibition of benzo[a]pyrene-induced forestomach carcinogenesis in mice by thymoquinone. EurJ Cancer Prev 1999; 8: 435-40
99. El Mezayen E, El Gazzar M, Nicolls MR, JMarecki JC, Dreskin SC, Nomiyama H. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation, Immunol Lett 2006; 106: 72-81
100. Nagi MN, Mansour MA. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res 2000; 41: 283-9
101. El-Mahmoudy A, Matsuyama H, Borgan MA, Shimizu Y, El-Sayed MG, Minamoto N et al Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages, Int Immunopharmacol 2002; 2: 1603-11
102. El-Dakhakhny M, Madi NJ, Lembert N, Amman HP. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 2002; 81: 161-4
103. El-Mahmoudy A, Shimizu Y, Shiina T, Matsuyama H, Nikami H, Takewaki T. Macrophage-derived cytokine and nitric oxide profiles in type 1 and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol 2005; 42: 23-30
104. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 2004; 15: 389-99
105. Sethi G, Ahn KS, Aggarwal BB. Targeting NF-kB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res, in press
106. Yi T, Yi Z, Cho S, Pang X, Rodriguez M, Wang Y et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and ERK signaling pathways. MoI Cancer Ther, in press
107. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994; 54: 701-8
108. Tokuda H, Ohigashi H, Koshimizu K, Ito Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-0-tetradecanoyl-phorbol 13-acetate. Cancer Lett 1986; 33: 279-85
109. Ohigashi H, Takamura H, Koshimizu K, Tokuda H, Ito Y. Search for possible antitumor promoters by inhibition of 12-0-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L. Cancer Lett 1986; 30: 143-51
110. Nishino H, Nishino A, Takayasu J, Hasegawa T, Iwashima A, Hirabayashi K et al. Inhibition of the tumor-promoting action of 12-0- tetradecanoylphorbol 13-acetate by some oleanane-type triterpenoid compounds. Cancer Res 1988; 48: 5210-5
111. Sohn KH, Lee HY, Chung HY, Young HS, Yi SY, Kim KW. Anti-angiogenic activity of triterpene acids. Cancer Lett 1995; 94: 213-8
112. Simon A, Najid A, Chulia AJ, Delage C, Rigaud M. Inhibition of lipoxygenase activity and HL60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris). Biochim Biophys Acta 1992; 1125: 68-72
113. Najid A, Simon A, Cook J, Chable-Rabinovitch H, Delage C, Chulia AJ et al. Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett 1992; 299: 213-7
114. Ringbom T, Segura L, Noreen Y, Perera P, Bohlin L. Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis. J Nat Prod 1998; 61: 1212-5
115. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res 2000; 60: 2399-404
116. Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M et al. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 1996; 56: 2281-4
117. Cha HJ, Park MT, Chung HY, Kim ND, Sato H, Seiki M, et al. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells. Oncogene 1998; 16: 771-8
118. Es-Saady D, Simon A, Jayat-Vignoles C, Chulia AJ, Delage C. MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts. Anticancer Res 1996; 16: 481-6
119. Es-Saady D, Simon A, Oilier M, Maurizis JC, Chulia AJ, Delage C. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett 1996; 106: 193-7
120. Choi BM, Park R, Pae HO, Yoo JC, Kim YC, Jun CD et al. Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells. Pharmacol Toxicol 2000; 86: 53-8
121. Choi YH, Baek JH, Yoo MA, Chung HY, Kim ND, Kim KW. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. Int J Oncol 2000; 17: 565-71
122. Hollosy F, Meszaros G, Bokonyi G, Idei M, Seprodi A, Szende B et al. Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells. Anticancer Res 2000; 20: 4563-70
123. Hollosy F, Idei M, Csorba G, Szabo E, Bokonyi G, Seprodi A et al. Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis. Anticancer Res 2001; 21: 3485-91
124. Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE et al. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood 2002; 99: 326-35
125. Kim DK, Baek JH, Kang CM, Yoo MA, Sung JW, Chung HY et al. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication, Int J Cancer 2000; 87: 629-36
126. Baek JH, Lee YS, Kang CM, Kim JA, Kwon KS, Son HC et al. Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J Cancer 1997; 73: 725-8
127. Lauthier F, Taillet L, Trouillas P, Delage C, Simon A. Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs 2000; 11: 737-45
128. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 2003; 63: 4375-83
129. Pathak AK, Bhutani M, Nair AS, Ahn KS, Chakraborty A, Kadara H et al. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol Cancer Res 2007; 5: 943-55
130. Shukla Y, Prasad S, Tripathi C, Singh M, George J, Kalra N. In vitro and in vivo modulation of testosterone mediated alterations in apoptosis related proteins by [6]-gingerol. Mol Nutr Food Res 2007; 51: 1492-502
131. Ishiguro K, Ando T, Maeda O, Ohmiya N, Niwa Y, Kadomatsu K et al. Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms. Biochem Biophys Res Commun 2007; 362: 218-23
132. Lee HS, Seo EY, Kang NE, Kim WK. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem 2008; 19: 313-9
133. Bode AM, Ma WY, Surh YJ, Dong Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 2001; 61: 850-3
134. Kim EC, Min JK, Kim TY, Lee SJ, Yang HO, Han S et al. [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 2005; 335: 300-8
135. Kim SO, Own KS, Kundu JK, Surh YJ. Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 2004; 21: 27-31
136. Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008; 47: 197-208
137. Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review), Int J Oncol 2007; 30: 233-45
138. Manju V, Nalini N. Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem Funct 2007; 25: 189-94